Literature DB >> 28528775

Structural Basis for Apelin Control of the Human Apelin Receptor.

Yingli Ma1, Yang Yue2, Yanbin Ma1, Qing Zhang1, Qingtong Zhou2, Yunpeng Song1, Yuqing Shen1, Xun Li1, Xiaochuan Ma1, Chao Li3, Michael A Hanson4, Gye Won Han5, E Allen Sickmier6, Gayathri Swaminath7, Suwen Zhao8, Raymond C Stevens8, Liaoyuan A Hu1, Wenge Zhong1, Mingqiang Zhang1, Fei Xu9.   

Abstract

Apelin receptor (APJR) is a key regulator of human cardiovascular function and is activated by two different endogenous peptide ligands, apelin and Elabela, each with different isoforms diversified by length and amino acid sequence. Here we report the 2.6-Å resolution crystal structure of human APJR in complex with a designed 17-amino-acid apelin mimetic peptide agonist. The structure reveals that the peptide agonist adopts a lactam constrained curved two-site ligand binding mode. Combined with mutation analysis and molecular dynamics simulations with apelin-13 binding to the wild-type APJR, this structure provides a mechanistic understanding of apelin recognition and binding specificity. Comparison of this structure with that of other peptide receptors suggests that endogenous peptide ligands with a high degree of conformational flexibility may bind and modulate the receptors via a similar two-site binding mechanism.
Copyright © 2017 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  apelin recognition and binding specificity; cardiovascular drug target; designed agonist peptide mimic; human apelin receptor

Mesh:

Substances:

Year:  2017        PMID: 28528775     DOI: 10.1016/j.str.2017.04.008

Source DB:  PubMed          Journal:  Structure        ISSN: 0969-2126            Impact factor:   5.006


  31 in total

Review 1.  The apelinergic system: a perspective on challenges and opportunities in cardiovascular and metabolic disorders.

Authors:  Eric Marsault; Catherine Llorens-Cortes; Xavier Iturrioz; Hyung J Chun; Olivier Lesur; Gavin Y Oudit; Mannix Auger-Messier
Journal:  Ann N Y Acad Sci       Date:  2019-06-25       Impact factor: 5.691

Review 2.  Understanding Peptide Binding in Class A G Protein-Coupled Receptors.

Authors:  Irina G Tikhonova; Veronique Gigoux; Daniel Fourmy
Journal:  Mol Pharmacol       Date:  2019-07-10       Impact factor: 4.436

3.  A benchmark study of loop modeling methods applied to G protein-coupled receptors.

Authors:  Lee H Wink; Daniel L Baker; Judith A Cole; Abby L Parrill
Journal:  J Comput Aided Mol Des       Date:  2019-05-23       Impact factor: 3.686

4.  Lipid-Protein Interactions Are a Unique Property and Defining Feature of G Protein-Coupled Receptors.

Authors:  Besian I Sejdiu; D Peter Tieleman
Journal:  Biophys J       Date:  2020-03-20       Impact factor: 4.033

5.  In Silico Studies Targeting G-protein Coupled Receptors for Drug Research Against Parkinson's Disease.

Authors:  Agostinho Lemos; Rita Melo; Antonio Jose Preto; Jose Guilherme Almeida; Irina Sousa Moreira; Maria Natalia Dias Soeiro Cordeiro
Journal:  Curr Neuropharmacol       Date:  2018       Impact factor: 7.363

6.  Structural basis of ligand recognition and self-activation of orphan GPR52.

Authors:  Xi Lin; Mingyue Li; Niandong Wang; Yiran Wu; Zhipu Luo; Shimeng Guo; Gye-Won Han; Shaobai Li; Yang Yue; Xiaohu Wei; Xin Xie; Yong Chen; Suwen Zhao; Jian Wu; Ming Lei; Fei Xu
Journal:  Nature       Date:  2020-02-19       Impact factor: 49.962

Review 7.  Advances in therapeutic peptides targeting G protein-coupled receptors.

Authors:  Anthony P Davenport; Conor C G Scully; Chris de Graaf; Alastair J H Brown; Janet J Maguire
Journal:  Nat Rev Drug Discov       Date:  2020-03-19       Impact factor: 84.694

8.  Distinctive Activation Mechanism for Angiotensin Receptor Revealed by a Synthetic Nanobody.

Authors:  Laura M Wingler; Conor McMahon; Dean P Staus; Robert J Lefkowitz; Andrew C Kruse
Journal:  Cell       Date:  2019-01-10       Impact factor: 41.582

Review 9.  Apelinergic System Structure and Function.

Authors:  Kyungsoo Shin; Calem Kenward; Jan K Rainey
Journal:  Compr Physiol       Date:  2017-12-12       Impact factor: 9.090

10.  Angiotensin AT1 receptor antagonism by losartan stimulates adipocyte browning via induction of apelin.

Authors:  Dong Young Kim; Mi Jin Choi; Tae Kyung Ko; Na Hyun Lee; Ok-Hee Kim; Hyae Gyeong Cheon
Journal:  J Biol Chem       Date:  2020-08-24       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.